What is Livzon Pharmaceutical Group Inc.'s (000513.SZ) StockRank?

MoatMap's StockRank for Livzon Pharmaceutical Group Inc. (000513.SZ) is 94/100, with a Strong Buy signal. This is a composite score combining Quality (74), Value (67), and Momentum (45) factor ranks across MoatMap's 19,000+ stock universe.

Does Livzon Pharmaceutical Group Inc. have an economic moat?

Livzon Pharmaceutical Group Inc. (000513.SZ) has a Quality factor score of 74/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Livzon Pharmaceutical Group Inc. a buy, hold, or sell?

MoatMap's current signal for Livzon Pharmaceutical Group Inc. (000513.SZ) is Strong Buy, based on a StockRank of 94/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Livzon Pharmaceutical Group Inc. in?

Livzon Pharmaceutical Group Inc. (000513.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

000513.SZ

STRONG BUYREMOVE

Livzon Pharmaceutical Group Inc. · Healthcare · China · $4.0B · Avg Vol: $24M/d

StockRank

P/E (TTM)

14.4x

ROE

15.1%

D/E

0.2x

Dividend %

4.5%

Director Trades · 180d

None in 180d →

Buybacks · 180d

$88.7M · 1d →

AI CONVICTION THESIS

Livzon Pharmaceutical is a solid Chinese healthcare company, but it lacks the global scale, regulatory moats, and high-utilization CDMO profile required to benefit from our CDMO Pricing Power theme.

COMPANY DESCRIPTION

Livzon Pharmaceutical Group is a diversified Chinese healthcare company engaged in the research, development, and manufacture of specialty pharmaceuticals, active pharmaceutical ingredients (APIs), and diagnostic reagents. The company holds leading market positions in gastroenterology, assisted reproduction, and oncology treatments. Its competitive advantage is sustained by a robust R&D pipeline in monoclonal antibodies and innovative biologics.

FINANCIAL SUMMARY

Year	2022	2023	2024	2025	CAGR
Revenue	1.9B	1.8B	1.7B	1.8B	-1.6%
EPS	0.30	0.31	0.33	0.34	3.6%
Shares	936M	924M	911M	888M	-5.1%
Debt	535M	612M	589M	452M	-5.4%
Equity	2.1B	2.1B	2.0B	2.1B	0.0%
Op CF	410M	480M	440M	465M	4.3%
Inv CF	-182M	-105M	-98M	-556M	—
Fin CF	-106M	-245M	-367M	-394M	—

PRICE (1M)-2.4%

SMA 50SMA 200

$4.71

RSI (14)

60.7

52W High

$6.63

From 52W High

0.7%

SCORE BREAKDOWN

Quality

ROIC

17.4%89.1

ROE

15.1%83.1

GP/Assets

32.3%68.7

Op. Margin

29.1%91.0

FCF/Assets

8.0%81.5

Piotroski

—83.5

Int. Cover

50.0x91.4

D/E Ratio

0.19x53.1

Current Ratio

1.96x36.0

Value

P/E (TTM)

14.4x74.6

EV/EBITDA

7.2x51.6

P/FCF

96.7x70.3

P/B

1.9x56.6

P/S

2.4x62.6

Div Yield

4.5%88.2

Momentum

52W High %

71%57.7

RS 6M

-19%56.7

SMA 50/200

0.91x35.8

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

+14%29.1

Q Growth

-9%32.1

FUNDAMENTALS

Market Cap

$4.0B

P/E (Forward)

12.7x

Gross Margin

65.8%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 000513.SZ are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
000513.SZ	Livzon Pharmaceutical Group Inc.(you)	$4.0B	94	STRONG BUY
002603.SZ	Shijiazhuang Yiling Pharmaceutical Co., Ltd.	$4.0B	96	STRONG BUY
600566.SS	Hubei Jumpcan Pharmaceutical Co., Ltd.	$3.8B	99	STRONG BUY
2096.HK	Simcere Pharmaceutical Group Limited	$3.3B	91	STRONG BUY
T14.SI	Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited	$3.2B	96	STRONG BUY
600380.SS	Joincare Pharmaceutical Group Industry Co.,Ltd.	$2.8B	94	STRONG BUY
000423.SZ	Dong-E-E-Jiao Co., Ltd.	$4.8B	99	STRONG BUY
000739.SZ	Apeloa Pharmaceutical Co.,Ltd	$2.8B	91	STRONG BUY
600750.SS	China Resources Jiangzhong Pharmaceutical Co.,Ltd	$2.4B	95	STRONG BUY
600535.SS	Tasly Pharmaceutical Group Co., Ltd	$3.1B	86	STRONG BUY

Peer medians: ROE 4.7% · P/E 27.9x · Gross margin 52.9%

Livzon Pharmaceutical Group Inc. (000513.SZ) — Stock Score Summary

Livzon Pharmaceutical Group Inc. (000513.SZ) has a MoatMap StockRank of 94/100 based on Quality (74/100), Value (67/100), and Momentum (45/100) factor scores. The current signal is STRONG BUY. Livzon Pharmaceutical is a solid Chinese healthcare company, but it lacks the global scale, regulatory moats, and high-utilization CDMO profile required to benefit from our CDMO Pricing Power theme.

Key Financial Metrics

Price	$4.71
Market Cap	$4.0B
P/E (TTM)	14.41
P/E (Forward)	12.69
Price/Book	1.95
Return on Equity	15.1%
Return on Invested Capital	17.4%
Debt/Equity	19.03
Gross Margin	65.8%
Operating Margin	29.1%
Revenue Growth	-9.7%
Dividend Yield	4.5%
Free Cash Flow	$42M

Livzon Pharmaceutical Group Inc. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Livzon Pharmaceutical Group Inc.’s (000513.SZ) StockRank?: MoatMap’s StockRank for Livzon Pharmaceutical Group Inc. (000513.SZ) is 94/100, with a Strong Buy signal. It is a composite of Quality (74), Value (67), and Momentum (45) factor ranks across MoatMap’s 19,000+ stock universe.
Does Livzon Pharmaceutical Group Inc. have an economic moat?: Livzon Pharmaceutical Group Inc. (000513.SZ) has a Quality factor score of 74/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Livzon Pharmaceutical Group Inc. a buy, hold, or sell?: MoatMap’s current signal for Livzon Pharmaceutical Group Inc. (000513.SZ) is Strong Buy, based on a StockRank of 94/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Livzon Pharmaceutical Group Inc. in?: Livzon Pharmaceutical Group Inc. (000513.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).